Grainger David J

Chief Innovation Officer at CNTA

Sold, on record
$21k
Dollars the filings state
Form 4 sales
1
Latest Oct 3, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CNTACentessa Pharmaceuticals plcChief Innovation Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CNTAPlan not stated
    Oct 3, 2022 2022

    Sold 5,181 shares at $4.00 ($21k)

    Grainger David J, Chief Innovation Officer

    Sold 0.6% of holdings ($3.7M position)908,575 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Grainger David J
Source
Oct 3, 2022Oct 4, 2022CNTAChief Innovation OfficerForm 4 sale5,181$21k0.6%Plan not statedSEC